{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:46:26Z","timestamp":1789609586928,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inborn errors of immunity (IEI) with atopy (IEI-A) are a subgroup of IEIs with eczema as a prominent clinical feature that can mimic atopic dermatitis (AD). However, IEI-A-associated eczema can differ from that of classic AD, and its frequency, genotype-specific clinical patterns and temporal relationships with other manifestations of IEI-A (infections, allergic manifestations, autoimmunity) remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterize the frequency of eczema, timing and phenotypes in patients with IEI-A, and to explore the relationship of eczema with other clinical manifestations of IEI-A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study used data from the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), focusing on patients with genetically defined IEI-A followed in three large CEREDIH-participating centres and available clinical data. Eczema frequency and onset in relationship to other clinical events, particularly severe-or-unusual infections, was assessed, as were eczema phenotypes, concomitant allergic manifestations, treatments and autoimmunity. Clustering analyses were computed to identify distinct IEI-A eczema-associated clinical phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 373 patients with IEI-A, varying widely by genotype, 50.9% (n = 190) had eczema. All patients deficient in DOCK8 (dedicator of cytokinesis-8) were affected, followed by those deficient in FOXP3 (n = 22\/30; 73%) and those with STAT3 loss of function (n = 44\/59; 75%). Onset was usually early (median 4\u2005months). Eczema frequency and clinical presentation varied markedly across IEI-A genotypes; four phenotypic clusters were identified, with particular localizations and severe pruritus being strongly associated with pathogenic STAT3 or DOCK8 variants. For children with isolated eczema at 24\u2005months, the risk of developing IEI-related severe or unusual infections was lower than that of persistent isolated eczema until the age of 6.8\u2005years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Eczema is a common, early feature of IEI-A, often preceding infections by years. While 38.4% (n = 73\/190) of patients with IEI-A with eczema fulfilled the UK Working Party diagnostic criteria for AD, some clinical pictures may differ from that of classic AD. At a time when systemic AD treatments are rapidly advancing in paediatrics, recognizing these patterns to identify patients with IEI-A could refine diagnostic strategies, improve IEI detection among children with eczema, shorten the time to IEI-A diagnosis, guide tailored management and ensure patients receive the optimal care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljag308","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:29:36Z","timestamp":1784633376000},"source":"Crossref","is-referenced-by-count":1,"title":["Eczema in inborn errors of immunity with atopy: frequency, timing and phenotypic\u00a0clustering"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-9900","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Aubert","sequence":"first","affiliation":[{"name":"Dermatology Department, Nantes University Hospital , Nantes ,","place":["France"]},{"name":"Constitutive Site of the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), Nantes University Hospital , Nantes ,","place":["France"]},{"name":"UR1268, INRAE Pays de la Loire , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0030-8094","authenticated-orcid":false,"given":"Nizar","family":"Mahlaoui","sequence":"additional","affiliation":[{"name":"CEREDIH, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]},{"name":"Pediatric Immuno-Hematology and Rheumatology Unit, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6629-9100","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[{"name":"Dermatology Department, Nantes University Hospital , Nantes ,","place":["France"]},{"name":"Constitutive Site of the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), Nantes University Hospital , Nantes ,","place":["France"]},{"name":"UR1268, INRAE Pays de la Loire , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6635-2170","authenticated-orcid":false,"given":"Micka\u00ebl","family":"Alligon","sequence":"additional","affiliation":[{"name":"CEREDIH, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-4712","authenticated-orcid":false,"given":"Isabelle","family":"Pellier","sequence":"additional","affiliation":[{"name":"Pediatric Immuno-Hematology-Oncology, CHU Angers, University of Angers , Angers ,","place":["France"]},{"name":"Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes , Inserm, CNRS, CRCI2NA, SFR ICAT, Angers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-4057","authenticated-orcid":false,"given":"Coralie","family":"Mallebranche","sequence":"additional","affiliation":[{"name":"Pediatric Immuno-Hematology-Oncology, CHU Angers, University of Angers , Angers ,","place":["France"]},{"name":"Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes , Inserm, CNRS, CRCI2NA, SFR ICAT, Angers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-2482","authenticated-orcid":false,"given":"Jacinta","family":"Bustamante","sequence":"additional","affiliation":[{"name":"CEREDIH, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]},{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch , Paris ,","place":["France"]},{"name":"Paris Cit\u00e9 University, Imagine Institute , INSERM U1163, Paris ,","place":["France"]},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-161X","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie","family":"Rosain","sequence":"additional","affiliation":[{"name":"CEREDIH, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]},{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch , Paris ,","place":["France"]},{"name":"Paris Cit\u00e9 University, Imagine Institute , INSERM U1163, Paris ,","place":["France"]},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8788-5056","authenticated-orcid":false,"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[{"name":"CEREDIH, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]},{"name":"Pediatric Immuno-Hematology and Rheumatology Unit, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-5794","authenticated-orcid":false,"given":"Antoine","family":"N\u00e9el","sequence":"additional","affiliation":[{"name":"Constitutive Site of the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), Nantes University Hospital , Nantes ,","place":["France"]},{"name":"Internal Medicine Department, Nantes University Hospital , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-4657","authenticated-orcid":false,"given":"Marie","family":"Bodinier","sequence":"additional","affiliation":[{"name":"UR1268, INRAE Pays de la Loire , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3557-1538","authenticated-orcid":false,"given":"Carole","family":"Brosseau","sequence":"additional","affiliation":[{"name":"UR1268, INRAE Pays de la Loire , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-6234","authenticated-orcid":false,"given":"Laura","family":"Polivka","sequence":"additional","affiliation":[{"name":"CEREDIH, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]},{"name":"Dermatology Department, Necker Enfants-Malades University Hospital, APHP, Paris Cit\u00e9 Universit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-0905","authenticated-orcid":false,"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[{"name":"CEREDIH, Necker Enfants-Malades University Hospital , Assistance Publique\u2013H\u00f4pitaux de Paris (APHP), Paris ,","place":["France"]},{"name":"Dermatology Department, Necker Enfants-Malades University Hospital, APHP, Paris Cit\u00e9 Universit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-9317","authenticated-orcid":false,"given":"Caroline","family":"Thomas","sequence":"additional","affiliation":[{"name":"Constitutive Site of the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), Nantes University Hospital , Nantes ,","place":["France"]},{"name":"Pediatric Immuno-Hematology and Oncology, Nantes University Hospital , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2026090304215819600_ljag308-B1","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J Hum Immun"},{"key":"2026090304215819600_ljag308-B2","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"2026090304215819600_ljag308-B3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaci.2024.12.1075","article-title":"Update on inborn errors of immunity","volume":"155","author":"IJspeert","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"2026090304215819600_ljag308-B4","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3389\/fimmu.2019.01272","article-title":"The German National Registry of Primary Immunodeficiencies (2012\u20132017)","volume":"10","author":"El-Helou","year":"2019","journal-title":"Front Immunol"},{"key":"2026090304215819600_ljag308-B5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cei.13125","article-title":"The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017","volume":"192","author":"Shillitoe","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2026090304215819600_ljag308-B6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaci.2017.06.020","article-title":"Prevalence of primary immunodeficiencies in France is underestimated","volume":"140","author":"Mahlaoui","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026090304215819600_ljag308-B7","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250007","article-title":"Inborn errors of immunity: Manifestation, treatment, and outcome \u2013 an ESID registry 1994\u20132024 report on 30,628 patients","volume":"1","author":"Kindle","year":"2025","journal-title":"J Hum Immun"},{"key":"2026090304215819600_ljag308-B8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clim.2010.02.021","article-title":"The French national registry of primary immunodeficiency diseases","volume":"135","author":"CEREDIH: The French PID study group","year":"2010","journal-title":"Clin Immunol"},{"key":"2026090304215819600_ljag308-B9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/MOP.0000000000001331","article-title":"Clinical updates in inborn errors of immunity: a focus on the noninfectious clinical manifestations","volume":"36","author":"Campbell","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"2026090304215819600_ljag308-B10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.20172306","article-title":"Primary atopic disorders","volume":"215","author":"Lyons","year":"2018","journal-title":"J Exp Med"},{"key":"2026090304215819600_ljag308-B11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2021.08.008","article-title":"Inborn errors of immunity manifesting as atopic disorders","volume":"148","author":"Vaseghi-Shanjani","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2026090304215819600_ljag308-B12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2133.1994.tb08532.x","article-title":"The U.K. Working Party\u2019s Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation","volume":"131","author":"Williams","year":"1994","journal-title":"Br J Dermatol"},{"key":"2026090304215819600_ljag308-B13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.aller.2013.02.004","article-title":"Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis","volume":"42","author":"Aghamohammadi","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2026090304215819600_ljag308-B14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221755","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J Exp Med"},{"key":"2026090304215819600_ljag308-B15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clim.2010.04.011","article-title":"Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"136","author":"Zemble","year":"2010","journal-title":"Clin Immunol"},{"key":"2026090304215819600_ljag308-B16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11882-023-01071-4","article-title":"Chromosome 22q11.2 deletion (DiGeorge syndrome): immunologic features, diagnosis, and management","volume":"23","author":"Biggs","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"2026090304215819600_ljag308-B17","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood.2018885244","article-title":"Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center","volume":"133","author":"Giardino","year":"2019","journal-title":"Blood"},{"key":"2026090304215819600_ljag308-B18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/all.13401","article-title":"Epidemiology of atopic dermatitis in adults: results from an international survey","volume":"73","author":"Barbarot","year":"2018","journal-title":"Allergy"},{"key":"2026090304215819600_ljag308-B19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2020.12.020","article-title":"Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026090304215819600_ljag308-B20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"2026090304215819600_ljag308-B21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627651","article-title":"Wiskott Aldrich syndrome: a multi-institutional experience from India","volume":"12","author":"Suri","year":"2021","journal-title":"Front Immunol"},{"key":"2026090304215819600_ljag308-B22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the Wiskott\u2013Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J Pediatr"},{"key":"2026090304215819600_ljag308-B23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaci.2014.12.1945","article-title":"The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency","volume":"136","author":"Engelhardt","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026090304215819600_ljag308-B24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","article-title":"Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"160","author":"Halabi-Tawil","year":"2009","journal-title":"Br J Dermatol"},{"key":"2026090304215819600_ljag308-B25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1399-3038.2005.00259.x","article-title":"Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome) and patients with chronic granulomatous disease","volume":"16","author":"Staple","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"key":"2026090304215819600_ljag308-B26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2011.01.001","article-title":"Paucity of genotype\u2013phenotype correlations in STAT3 mutation positive hyper IgE syndrome (HIES)","volume":"139","author":"Heimall","year":"2011","journal-title":"Clin Immunol"},{"key":"2026090304215819600_ljag308-B27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaad.2018.09.035","article-title":"A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics","volume":"80","author":"Yew","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026090304215819600_ljag308-B28","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s10875-023-01554-z","article-title":"Atypical localization of eczema discriminates DOCK8 or STAT3 deficiencies from atopic dermatitis","volume":"43","author":"Kasap","year":"2023","journal-title":"J Clin Immunol"},{"key":"2026090304215819600_ljag308-B29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jaad.2010.09.714","article-title":"Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis","volume":"65","author":"Olaiwan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2026090304215819600_ljag308-B30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaci.2023.12.020","article-title":"Regulatory T-cell dysfunction and cutaneous exposure to Staphylococcus aureus underlie eczema in DOCK8 deficiency","volume":"154","author":"Wilkie","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2026090304215819600_ljag308-B31","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1038\/s41598-017-11803-y","article-title":"IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation","volume":"7","author":"Mitchell","year":"2017","journal-title":"Sci Rep"},{"key":"2026090304215819600_ljag308-B32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 hyper-IgE syndrome \u2013 an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J Clin Immunol"},{"key":"2026090304215819600_ljag308-B33","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100657","article-title":"Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: a worldwide study","volume":"15","author":"El-Sayed","year":"2022","journal-title":"World Allergy Organ J"},{"key":"2026090304215819600_ljag308-B34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaad.2024.09.029","article-title":"Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: a nationwide study","volume":"92","author":"Guillemin","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"2026090304215819600_ljag308-B35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/pde.15397","article-title":"Severe eczema in Wiskott\u2013Aldrich syndrome-related disorder successfully treated with dupilumab","volume":"41","author":"Alzahrani","year":"2024","journal-title":"Pediatr Dermatol"},{"key":"2026090304215819600_ljag308-B36","article-title":"Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis","volume":"13","author":"Caruso","year":"2022","journal-title":"Front Immunol"},{"key":"2026090304215819600_ljag308-B37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10875-023-01636-y","article-title":"Management of atopy with dupilumab and omalizumab in CADINS disease","volume":"44","author":"Diaz-Cabrera","year":"2024","journal-title":"J\u00a0Clin Immunol"},{"key":"2026090304215819600_ljag308-B38","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/pde.14717","article-title":"Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"38","author":"Maher","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"2026090304215819600_ljag308-B39","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108452","article-title":"Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome","volume":"215","author":"Sogkas","year":"2020","journal-title":"Clin Immunol"},{"key":"2026090304215819600_ljag308-B40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1346-8138.16253","article-title":"Successful treatment of Netherton syndrome with dupilumab: a case report and review of the literature","volume":"49","author":"Wang","year":"2022","journal-title":"J Dermatol"},{"key":"2026090304215819600_ljag308-B41","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13770","article-title":"Remission of eczema and recovery of Th1 polarization following treatment with dupilumab in STAT3 hyper IgE syndrome","volume":"33","author":"Matucci-Cerinic","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"2026090304215819600_ljag308-B42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2026090304215819600_ljag308-B43","doi-asserted-by":"crossref","first-page":"1400348","DOI":"10.3389\/fimmu.2024.1400348","article-title":"JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review","volume":"15","author":"Atschekzei","year":"2024","journal-title":"Front Immunol"},{"key":"2026090304215819600_ljag308-B44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"key":"2026090304215819600_ljag308-B45","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1129249","article-title":"Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement","volume":"11","author":"Giancotta","year":"2023","journal-title":"Front Pediatr"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag308\/69807068\/ljag308.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag308\/69807068\/ljag308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:22:15Z","timestamp":1788423735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article\/doi\/10.1093\/bjd\/ljag308\/8740081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljag308","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"ljag308"}}